AUD 0.92
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 695.99 Thousand AUD | -47.99% |
2023 | 1.33 Million AUD | -7.16% |
2022 | 1.44 Million AUD | 414.48% |
2021 | 280.14 Thousand AUD | 224.24% |
2020 | -225.47 Thousand AUD | -20.25% |
2019 | -187.51 Thousand AUD | -214.94% |
2018 | -59.53 Thousand AUD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 FY | 660.24 Thousand AUD | -50.66% |
2024 Q4 | 98.97 Thousand AUD | 846.92% |
2024 Q3 | 49.48 Thousand AUD | -91.18% |
2024 Q1 | 298.51 Thousand AUD | -51.4% |
2024 Q2 | 561.27 Thousand AUD | 88.02% |
2023 Q4 | 614.16 Thousand AUD | 80.65% |
2023 Q2 | 723.94 Thousand AUD | 96.61% |
2023 FY | 1.33 Million AUD | -7.16% |
2023 Q1 | 368.2 Thousand AUD | -53.66% |
2023 Q3 | 339.96 Thousand AUD | -53.04% |
2022 Q2 | 630.59 Thousand AUD | 95.04% |
2022 Q1 | 323.31 Thousand AUD | 224.29% |
2022 FY | 1.44 Million AUD | 414.48% |
2022 Q4 | 794.63 Thousand AUD | 91.85% |
2022 Q3 | 414.2 Thousand AUD | -34.32% |
2021 Q4 | -260.12 Thousand AUD | -723.02% |
2021 FY | 280.14 Thousand AUD | 224.24% |
2021 Q3 | 41.75 Thousand AUD | 102.58% |
2021 Q2 | -1.61 Million AUD | -1496.58% |
2021 Q1 | 115.74 Thousand AUD | 289.31% |
2020 FY | -225.47 Thousand AUD | -20.25% |
2020 Q2 | -164.33 Thousand AUD | -688.02% |
2020 Q4 | -61.13 Thousand AUD | -190.02% |
2020 Q3 | 67.91 Thousand AUD | 141.33% |
2020 Q1 | 27.94 Thousand AUD | 0.0% |
2019 FY | -187.51 Thousand AUD | -214.94% |
2018 FY | -59.53 Thousand AUD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Althea Group Holdings Limited | 2.13 Million AUD | 67.355% |
Cann Group Limited | 3.19 Million AUD | 78.216% |
ECS Botanics Holdings Ltd | 7.51 Million AUD | 90.735% |
Ecofibre Limited | -1.08 Million AUD | 164.384% |
Elixinol Wellness Limited | -1.8 Million AUD | 138.581% |
Hygrovest Limited | 260 Thousand AUD | -167.69% |
IDT Australia Limited | 6.7 Million AUD | 89.615% |
Invion Limited | 1 Million AUD | 30.625% |
Little Green Pharma Ltd | 11.97 Million AUD | 94.189% |
Medical Developments International Limited | -2.5 Million AUD | 127.84% |
Vitura Health Limited | 34.21 Million AUD | 97.966% |
Vita Life Sciences Limited | 42.6 Million AUD | 98.366% |